Gilead posts Q2 revenue at $6.2B, up 21% YoY

Gilead Sciences Inc. on Thursday announced its second-quarter revenue climbed 21% to $6.15 billion. Total costs and expenses were down 105% to $3.97 billion. Net income jumped from negative territory …